HomeProductsBuilding BlocksFunctional GroupsEstersLeucyl-leucine-methyl ester
Chemical structure of CAS 13022-42-9

Leucyl-leucine-methyl ester

CAS No.13022-42-9
MDL No.N/A
MFC13H26N2O3
MW258.36
InChI KeyAJMOLNFDYWTVQW-QWRGUYRKSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

L-leucyl-L-leucine methyl ester is a methyl ester of the dipeptide L-leucyl-L-leucine.

CAS No.13022-42-9
Product NameLeucyl-leucine-methyl ester
Heavy Atom Count18Rotatable Bond Count7
Atom Stereo Count2Bond Stereo Count0
HBA4HBD2
TPSA81.420 ŲCharge0
Exact Mass258.19434Complexity277.41
pKa7.130XLogP1.064

Related Articles

Studies related to this compound and its mechanism of action

MAGUKs, scaffolding proteins at cell junctions, are substrates of different proteases during apoptosis.

Cell death & disease • Vol. 2, Issue 1 • 2011
PMID: 21368887PMC: PMC3077288DOI: 10.1038/cddis.2010.92

Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • Vol. 15, Issue 12 • 2009
PMID: 19744572PMC: PMC2783272DOI: 10.1016/j.bbmt.2009.08.020

Anti-peptide antibody production elicited by in vitro immunization of human peripheral blood mononuclear cells.

Bioscience, biotechnology, and biochemistry • Vol. 71, Issue 12 • 2007
PMID: 18071242DOI: 10.1271/bbb.60460

Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.

BMC biotechnology • Vol. 7 • 2007
PMID: 17714596PMC: PMC2025598DOI: 10.1186/1472-6750-7-51

Documentation

Similar Products